From: Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome
All participants (cases and controls) | |||
---|---|---|---|
Variable | Mean (95% CI) or number (percentage) | ||
Healthy control (n = 40) | Multiple sclerosis (n = 20) | ME/CFS (n = 40) | |
Age (years)** | 42.9 (39.1–46.6) | 52.7 (49.8–55.6) | 44.1 (40.1–48) |
BMI (Kg/m2) | 25.9 (24.4–27.4) | 24.7 (23–26.4) | 25.6 (23.8–27.4) |
eGFR (ml/min/1.73 m2) | 82.7(79.3–86.1) | 75.2 (71–79.5) | 79.5 (75.5–83.5) |
Female sex | 23 (57.5%) | 15 (75%) | 27 (67.5%) |
Current smoking | 1 (2.5%) | 4 (20%) | 4 (10%) |
ME/CFS cases | ||
---|---|---|
Variable | Mean (95% CI) or number (percentage) | |
Non-severe cases (n = 24) | Severe cases (n = 16) | |
Age (years) | 47 (42–51.9) | 39.8 (33–46.5) |
BMI (Kg/m2)* | 27.1 (24.9–29.3) | 22.9 (20.1–25.7) |
eGFR (ml/min/1.73 m2)** | 74.7 (69.4–80) | 86.5 (81.8–91.2) |
Female sex | 16 (66.7%) | 11 (68.8%) |
Current smoking | 3 (12.5%) | 1 (6.2%) |